BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Isabel Theresa Schobert, Lynn Jeanette Savic, Julius Chapiro, Khaled Bousabarah, Evan Chen, Fabian Laage-Gaupp, Jonathan Tefera, Nariman Nezami, MingDe Lin, Jeffrey Pollak, Todd Schlachter. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACEEuropean Radiology 2020; 30(10): 5663 doi: 10.1007/s00330-020-06931-5
2
Zhong-Guo Zhou, Xing-Rong Zheng, Qian Zhou, Ming Shi, Yao-Jun Zhang, Rong-Ping Guo, Yun-Fei Yuan, Min-Shan Chen, Xiao-Jun Lin, Xiang-Ming Lao, Sheng-Ping Li. Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolizationChinese Journal of Cancer 2015; 34(3) doi: 10.1186/s40880-015-0017-7
3
Rong-xin Chen, Yu-hong Gan, Ning-lin Ge, Yi Chen, Hui Ma, Yan Wang, Bo-heng Zhang, Yan-hong Wang, Sheng-long Ye, Jian-feng Luo, Zheng-gang Ren. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matchingJournal of Gastroenterology and Hepatology 2016; 31(2): 442 doi: 10.1111/jgh.13077
4
Kenji KUTARA, Toshiaki KONNO, Hirotaka KONDO, Hinako YAMAZOE, Satoru MATSUNAGA. Triple-phase helical computed tomography of an arterio-hepatic venous shunt in a hepatic tumor in a dogJournal of Veterinary Medical Science 2017; 79(12): 1947 doi: 10.1292/jvms.17-0373
5
Yang Jun Kang, Byung Chan Lee, Jae Kyu Kim, Nam Yeol Yim, Hyoung Ook Kim, Soo Buem Cho, Yong Yeon Jeong. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular CarcinomaCardioVascular and Interventional Radiology 2020; 43(1): 55 doi: 10.1007/s00270-019-02349-9
6
Mohammed Bermo, Manuela C. Matesan, Malak Itani, Fatemeh Behnia, Hubert J. Vesselle. Hepatopulmonary shunting on Tc99m-MAA liver mapping: correlation with dynamic cross-sectional imaging and description of different shunting patternsAbdominal Radiology 2018; 43(11): 3001 doi: 10.1007/s00261-018-1602-4
7
Samuel R. Falkson, Hriday P. Bhambhvani, Melanie Hayden Gephart. Hepatocellular Carcinoma Brain Metastases: A Single-Institution ExperienceWorld Neurosurgery 2020; 140: e27 doi: 10.1016/j.wneu.2020.03.189
8
Xihai Wang, Hongyuan Liang, Zaiming Lu. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablationMinimally Invasive Therapy & Allied Technologies 2019; : 1 doi: 10.1080/13645706.2019.1649286
9
Natsuhiko Saito, Toshihiro Tanaka, Hideyuki Nishiohuku, Takeshi Sato, Tetsuya Masada, Takeshi Matsumoto, Hiroshi Anai, Hiroshi Sakaguchi, Satoru Sueyoshi, Nagaaki Marugami, Kimihiko Kichikawa. Transarterial‐ chemoembolization remains an effective therapy for intermediate‐stage hepatocellular carcinoma with preserved liver functionHepatology Research 2020; 50(10): 1176 doi: 10.1111/hepr.13550
10
Huan Tong, Bo Wei, Shuang Chen, Yong-Mei Xie, Ming-Guang Zhang, Lin-Hao Zhang, Zhi-Yin Huang, Cheng-Wei Tang. Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot studyOncotarget 2017; 8(29): 48303 doi: 10.18632/oncotarget.15684
11
Maureen P. Kohi. Gender-Related Differences in Hepatocellular Carcinoma: Does Sex Matter?Journal of Vascular and Interventional Radiology 2016; 27(9): 1338 doi: 10.1016/j.jvir.2016.06.035
12
Stuart K. Roberts, Alessia Gazzola, John Lubel, Paul Gow, Sally Bell, Amanda Nicoll, Anouk Dev, Michael A. Fink, Siddharth Sood, Virginia Knight, Thai Hong, Eldho Paul, Gauri Mishra, Ammar Majeed, William Kemp. Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalScandinavian Journal of Gastroenterology 2018; 53(10-11): 1368 doi: 10.1080/00365521.2018.1517277
13
Aline Mähringer-Kunz, Arndt Weinmann, Irene Schmidtmann, Sandra Koch, Sebastian Schotten, Daniel Pinto dos Santos, Michael Bernhard Pitton, Christoph Dueber, Peter Robert Galle, Roman Kloeckner. Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4407-5
14
Zhe Guo, Yuan Zhong, Bo Hu, Jing-Hang Jiang, Le-Qun Li, Bang-De Xiang. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteriaMedicine 2017; 96(51): e8933 doi: 10.1097/MD.0000000000008933
15
Rongxin Chen, Yuhong Gan, Ninglin Ge, Yi Chen, Yan Wang, Boheng Zhang, Yanhong Wang, Shenglong Ye, Zhenggang Ren. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative StudyJournal of Vascular and Interventional Radiology 2016; 27(12): 1829 doi: 10.1016/j.jvir.2016.06.010